http://purl.org/np/RAMDl6w7lX... RAMDl6w7lX

links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion

http://www.w3.org/1999/02/22-rdf-syntax-ns#type type

http://www.w3.org/1999/02/22-rdf-syntax-ns#Statement Statement

0000-0002-7641-6446

2021-08-24T15:53:57.790Z

http://purl.org/np/RAMDl6w7lX... RAMDl6w7lX

links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion

http://www.w3.org/2000/01/rdf-schema#label label

Paliperidone is FDA-approved for schizophrenia aged 12-17. However, the pharmacologic portfolio, extrapolation from adult studies, and the long track record of the parent drug, risperidone in child/adolescent psychiatric (CAP) population might expand its therapeutic potential. An 8-week open-label study [9] examined paliperidone monotherapy for acute mania, mixed, or hypomanic episode in pediatric patients (n = 15, 6–17 years of age) with bipolar spectrum disorders. At the end of follow-up period, 11 subjects (73%) completed the study; treatment with paliperidone was associated with a 60% response rate (50% decrease in the Young Mania Rating Scale) and 40% remission (YMRS <12)

0000-0002-7641-6446

2021-08-24T15:53:57.790Z

http://purl.org/np/RAMDl6w7lX... RAMDl6w7lX

links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion

http://www.w3.org/1999/02/22-rdf-syntax-ns#object object

http://purl.obolibrary.org/obo/MONDO_0005090 MONDO_0005090

0000-0002-7641-6446

2021-08-24T15:53:57.790Z

http://purl.org/np/RAMDl6w7lX... RAMDl6w7lX

links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion

http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate predicate

https://w3id.org/biolink/vocab/treats treats

0000-0002-7641-6446

2021-08-24T15:53:57.790Z

http://purl.org/np/RAMDl6w7lX... RAMDl6w7lX

links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion

http://www.w3.org/1999/02/22-rdf-syntax-ns#subject subject

https://identifiers.org/DRUGBANK:DB01267 DRUGBANK:DB01267

0000-0002-7641-6446

2021-08-24T15:53:57.790Z

http://purl.org/np/RAMDl6w7lX... RAMDl6w7lX

links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion

https://w3id.org/biolink/vocab/has_population_context has_population_context

http://purl.org/np/RAMDl6w7lX...#context context

0000-0002-7641-6446

2021-08-24T15:53:57.790Z

http://purl.org/np/RAMDl6w7lX... RAMDl6w7lX

links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion

https://w3id.org/biolink/vocab/publications publications

https://pubmed.ncbi.nlm.nih.gov/31096228 pubmed.ncbi.nlm.nih.gov/31096228

0000-0002-7641-6446

2021-08-24T15:53:57.790Z

http://purl.org/np/RAMDl6w7lX... RAMDl6w7lX

links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion

https://w3id.org/biolink/vocab/provided_by provided_by

https://w3id.org/um/NeuroDKG NeuroDKG

0000-0002-7641-6446

2021-08-24T15:53:57.790Z

http://purl.org/np/RAMDl6w7lX... RAMDl6w7lX

links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion

https://w3id.org/biolink/vocab/relation relation

https://w3id.org/um/neurodkg/OffLabelIndication OffLabelIndication

0000-0002-7641-6446

2021-08-24T15:53:57.790Z